改善受损动物模型中受损骨结合的策略
本文综述了在模拟骨质疏松、废用综合征和2型糖尿病等骨质量受损状况的啮齿动物模型中,通过微米、介观和纳米级表面形貌修饰(类似破骨细胞吸收陷窝)及亲水性处理,单独或联合生物制剂与局部治疗,可提高骨-种植体接触(BIC)和成骨活性,改善受损条件下的种植体骨结合。
要点
- 模拟骨质量受损的动物模型显示BIC降低或骨密度下降。
- 微/介观/纳米级表面形貌与亲水性修饰可增强成骨细胞反应。
- 表面修饰联合生物制剂或局部治疗是改善骨结合的可转化策略。
核心结论
- 表面修饰、生物活性涂层和局部治疗是改善受损条件下BIC和成骨活性的务实方法。
研究设计与样本
- 综述纳入了在模拟人类骨质量受损状况的啮齿动物模型中研究钛表面修饰的文献。
主要发现
- 在模拟骨质疏松、废用综合征和2型糖尿病的啮齿动物模型中观察到BIC降低或骨密度下降。
- 微米、介观和纳米级表面形貌修饰类似破骨细胞吸收陷窝,可有效改善种植体骨结合。
- 表面添加亲水性可进一步增强骨-种植体界面的成骨细胞反应。
- 表面修饰通过增加骨祖细胞增殖与成骨分化、增强血管生成并调节破骨细胞活性来实现净新骨形成。
- 骨髓基质细胞与免疫调节细胞间的通讯对这些表面性质敏感。
临床怎么用
- 临床医生可考虑使用表面修饰、生物活性涂层和局部治疗来提高受损患者的长期种植体性能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Implant osseointegration is reduced in patients with systemic conditions that compromise bone quality, such as osteoporosis, disuse syndrome, and type 2 diabetes. Studies using rodent models designed to mimic these compromised conditions demonstrated reduced bone-to-implant contact (BIC) or a decline in bone mineral density. These adverse effects are a consequence of disrupted intercellular communication. A variety of approaches have been developed to compensate for the altered microenvironment inherent in compromised conditions, including the use of biologics and implant surface modification. Chemical and physical modification of surface properties at the microscale, mesoscale, and nanoscale levels to closely resemble the surface topography of osteoclast resorption pits found in bone has proven to be a highly effective strategy for improving implant osseointegration. The addition of hydrophilicity to the surface further enhances osteoblast response at the bone-implant interface. These surface modifications, applied either alone or in combination, improve osseointegration by increasing proliferation and osteoblastic differentiation of osteoprogenitor cells and enhancing angiogenesis while modulating osteoclast activity to achieve net new bone formation, although the specific effects vary with surface treatment. In addition to direct effects on surface-attached cells, the communication between bone marrow stromal cells and immunomodulatory cells is sensitive to these surface properties. This article reports on the advances in titanium surface modifications, alone and in combination with novel therapeutics in animal models of human disease affecting bone quality. It offers clinically translatable perspectives for clinicians to consider when using different surface modification strategies to improve long-term implant performance in compromised patients. This review supports the use of surface modifications, bioactive coatings, and localized therapeutics as pragmatic approaches to improve BIC and enhance osteogenic activity from both structural and molecular standpoints.
引用
- Deng J, Van Duyn C, Cohen DJ, et al. Strategies for Improving Impaired Osseointegration in Compromised Animal Models. J Dent Res. 2024. PMID: 38616679. doi:10.1177/00220345241231777
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。